logo
How it worksCoursesResearch CommunitiesBenefitsAbout Us
Schedule Demo
Learn Before
Relation

Biomedical Engineering for COVID-19 Articles from MedRxiv

  • RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
  • Safety and Immunogenicity of the Ad26.COV2.S COVID-19 Vaccine Candidate: Interim Results of a Phase 1/2a, Double-blind, Randomized, Placebo-Controlled Trial
  • Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial -Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants

0

1

Updated 2020-11-23

Contributors are:

Breona Martin
Breona Martin
🏆 1
Saumya Baddela
Saumya Baddela
✔️ 1
Isabel Ball
Isabel Ball
✔️ 1
Sai Tummala
Sai Tummala
✔️ 1

Who are from:

San Jose State University
San Jose State University
🏆 1
University of California, Santa Cruz
University of California, Santa Cruz
✔️ 1
Bowdoin College
Bowdoin College
✔️ 1
Smith College
Smith College
✔️ 1

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences

Related
Learn After